Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

Boyle, 2008

Pao, 2004, EGF receptor gene mutations are common in lung cancers from ‘never smokers’ and are associated with sensitivity of tumors to gefitinib and erlotinib, Proc Natl Acad Sci USA, 101, 13306, 10.1073/pnas.0405220101

Mok, 2009, Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma, N Engl J Med, 361, 947, 10.1056/NEJMoa0810699

Motoi, 2008, Lung adenocarcinoma: modification of the 2004 WHO Mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis, Am J Surg Pathol, 32, 810, 10.1097/PAS.0b013e31815cb162

Noguchi, 1995, Small adenocarcinoma of the lung. Histologic characteristics and prognosis, Cancer, 75, 2844, 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#

Kim, 2001, Quantification of ground-glass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications, AJR Am J Roentgenol, 177, 1417, 10.2214/ajr.177.6.1771417

Wu, 2001, Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter, Ann Thorac Surg, 71, 1772, 10.1016/S0003-4975(01)02520-6

Travis, 2011, The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification, J Thoracic Oncol, 6, 244, 10.1097/JTO.0b013e318206a221

Tsutsumida, 2007, A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis, Mod Pathol, 20, 638, 10.1038/modpathol.3800780

Miyoshi, 2003, Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis, Am J Surg Pathol, 27, 101, 10.1097/00000478-200301000-00011

Amin, 2002, Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance, Am J Surg Pathol, 26, 358, 10.1097/00000478-200203000-00010

Gaeta, 2003, Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study, Lung Cancer, 42, 319, 10.1016/S0169-5002(03)00362-3

Marchetti, 1996, Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype, J Pathol, 179, 254, 10.1002/(SICI)1096-9896(199607)179:3<254::AID-PATH589>3.0.CO;2-J

Yatabe, 2004, CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas, J Pathol, 203, 645, 10.1002/path.1566

Goldstein, 2001, Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies, Am J Clin Pathol, 116, 319, 10.1309/550P-QLJX-D84W-F6DN

Garfield, 2009, The importance of distinguishing mucinous and nonmucinous bronchioloalveolar carcinomas, Lung, 187, 207, 10.1007/s00408-009-9149-3

Lee, 2009, Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons, Lung Cancer, 65, 170, 10.1016/j.lungcan.2008.11.009

Wislez, 2010, Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib, Lung Cancer, 68, 185, 10.1016/j.lungcan.2009.05.021

Finberg, 2007, Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features, J Mol Diagn, 9, 320, 10.2353/jmoldx.2007.060182

Cohen PR, Yoshizawa A, Motoi N, et al. Signet ring cell features (SRCF) in lung adenocarcinoma: a cytologic feature or a histologic subtype? Mod Pathol 2010;23.

Deshpande CG, Yoshizawa A, Motoi N, et al. Clear cell change in lung adenocarcinoma: a cytologic change rather than a histologic variant. Mod Pathol 2009;22.

Goldstraw, 2009

Rusch, 2009, Lung, 253

Sica, 2010, A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors, Am J Surg Pathol, 34, 1155, 10.1097/PAS.0b013e3181e4ee32

Travis, 2008, Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer, J Thorac Oncol, 3, 1384, 10.1097/JTO.0b013e31818e0d9f

Travis, 2004

Goldstraw, 2007, The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours, J Thorac Oncol, 2, 706, 10.1097/JTO.0b013e31812f3c1a

Barletta, 2010, Prognostic significance of grading in lung adenocarcinoma, Cancer, 116, 659, 10.1002/cncr.24831

Riquet, 2006, Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping, Ann Thorac Surg, 81, 1988, 10.1016/j.athoracsur.2006.01.021

Nagano, 2010, Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma, Lung Cancer, 67, 282, 10.1016/j.lungcan.2009.04.014

Kamiya, 2008, Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma, Mod Pathol, 21, 992, 10.1038/modpathol.2008.79

Kawakami, 2007, Micropapillary pattern and grade of stromal invasion in pT1 adenocarcinoma of the lung: usefulness as prognostic factors, Mod Pathol, 20, 514, 10.1038/modpathol.3800765

Makimoto, 2005, Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours), Histopathology, 46, 677, 10.1111/j.1365-2559.2005.02126.x

Daly, 1991, Bronchoalveolar carcinoma: factors affecting survival, Ann Thorac Surg, 51, 368, 10.1016/0003-4975(91)90847-J

Manning, 1984, Bronchioloalveolar carcinoma: the significance of two histopathologic types, Cancer, 54, 525, 10.1002/1097-0142(19840801)54:3<525::AID-CNCR2820540324>3.0.CO;2-X

Cadranel, 2009, IFCT-0401 Trial: a phase II study of gefitinib administered as first-line treatment in advanced adenocarcinoma with bronchioloalveolar carcinoma subtype, J Thorac Oncol, 4, 1126, 10.1097/JTO.0b013e3181abeb5d

Garfield, 2008, Bronchioloalveolar carcinoma: the case for two diseases, Clin Lung Cancer, 9, 24, 10.3816/CLC.2008.n.004

Clayton, 1986, Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates, Cancer, 57, 1555, 10.1002/1097-0142(19860415)57:8<1555::AID-CNCR2820570820>3.0.CO;2-N

Hayes DF, Allred C, Anderson BO, et al. Breast. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds), AJCC Cancer Staging Manual, 7th edn, Springer: New York, 2009.